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Abstract: Carbon-based electrodes combined with fast-scan cyclic voltammetry (FSCV) enable
neurochemical sensing with high spatiotemporal resolution and sensitivity. While their attractive
electrochemical and conductive properties have established a long history of use in the detection
of neurotransmitters both in vitro and in vivo, carbon fiber microelectrodes (CFMEs) also have lim-
itations in their fabrication, flexibility, and chronic stability. Diamond is a form of carbon with a
more rigid bonding structure (sp3-hybridized) which can become conductive when boron-doped.
Boron-doped diamond (BDD) is characterized by an extremely wide potential window, low back-
ground current, and good biocompatibility. Additionally, methods for processing and patterning
diamond allow for high-throughput batch fabrication and customization of electrode arrays with
unique architectures. While tradeoffs in sensitivity can undermine the advantages of BDD as a
neurochemical sensor, there are numerous untapped opportunities to further improve performance,
including anodic pretreatment, or optimization of the FSCV waveform, instrumentation, sp2/sp3
character, doping, surface characteristics, and signal processing. Here, we review the state-of-the-art
in diamond electrodes for neurochemical sensing and discuss potential opportunities for future
advancements of the technology. We highlight our team’s progress with the development of an all-
diamond fiber ultramicroelectrode as a novel approach to advance the performance and applications
of diamond-based neurochemical sensors.
Keywords: diamond; neurotransmitter; FSCV; electrode; sensing
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1. Introduction to Carbon-Based Sensors for Neurochemical Sensing
Disruption of chemical or electrical signaling in the brain underlies neurological disor-
ders such as addiction [1–3], Alzheimer’s disease [4–6], amyotrophic lateral sclerosis [7–11],
chronic pain [12–15], depression [16–18], Huntington’s disease [19–21], Parkinson’s dis-
ease [22–24], and schizophrenia [25–27]. Detection methods for sensing neurochemicals
in vivo for the study of neurological disorders would ideally be simultaneously sensitive,
minimally-invasive, chronically stable, and relatively inexpensive. In a recent review by
S. Niyonambaza et al., techniques for neurotransmitter (NT) identification and quantifi-
cation were discussed in depth [28], including positron emission tomography and single
photon NT identification and measurement [29–31], single-photon emission computed
tomography [32,33], surface-enhanced Raman spectroscopy [34,35], fast-scan cyclic voltam-
metry (FSCV) [36–38], amperometry [39,40], high performance liquid column chromatog-
raphy (HPLC) [41–43], fluorescence [44,45], optical fiber sensing [46,47], and colorimetric
measurements [48–50], as seen in Table 1. Longitudinal positron emission tomography
(PET), while non-invasive, is not adequately sensitive to detect subtle changes in dopamine
(DA) levels. While each available technique yields useful information, it is fast-scan cyclic
voltammetry (FSCV) and HPLC coupled with microdialysis that allow for high temporal
and spatial resolution for the detection of neurotransmitters (NTs) [51–54]. Of these two
techniques, HPLC-coupled microdialysis can have a temporal resolution of up to 1 min by
combining injection and analysis, separating and quantifying various NTs. Microdialysis
is a powerful technique due to its sensitivity, selectivity, and number of simultaneous
metabolites that can be separated and quantified [55]. Classically, however, microdialysis
lacks spatiotemporal resolution because it has a relatively large probe diameter (~200 µm)
and a typical sample collection time of every ~5–20 min [52,55,56]. Likewise, microdialysis
probes are associated with pronounced glial encapsulation and disruption of blood vessels
in comparison to small-diameter carbon fiber microelectrodes (CFMEs) traditionally used
for FSCV [57]. CFMEs detected a ~90% decrease in DA concentration within the immediate
vicinity of a microdialysis probe (~200 microns) in comparison to levels measured ~1 mm
away following probe insertion [58]. The relatively large scale of the microdialysis probe
may disrupt release and reuptake of the neurochemicals of interest. These results imply
that the accuracy of NT detection may be influenced by the tissue damage caused by
microdialysis probes, motivating the development of improved technology.
As an alternative, FSCV has been used to measure sub-second neurochemical sig-
naling through electrochemical detection in situ [59]. FSCV has been widely used for
real-time detection of NTs and other important bioanalytes, including oxygen (O2) and
pH change. It provides improved spatiotemporal resolution compared to other short-time
scale electroanalytical techniques such as chronoamperometry (CA). The technique uses
an ultramicroelectrode with a small biological footprint (~7 µm in diameter) to produce
a background-subtracted signal with high temporal resolution and nanomolar sensitiv-
ity [38,60–66]. FSCV involves two central steps: (1) adsorption of electroactive species
of interest (e.g., neurochemicals) to the electrode surface is favored by the application
of a small DC holding potential, and (2) a triangular voltage pulse is repeatedly swept
across the interface to produce signature peaks in Faradaic current which result from
oxidation/reduction of adsorbed neurochemicals. These peaks can be used to identify the
specific neurochemical (based on the corresponding potentials) as well as its concentration
(based on current amplitude). The typical voltage waveform that has been optimized to
achieve selectivity, sensitivity, and stability for measuring DA with CFMEs is an applied
potential swept from −0.4 to 1.3 to −0.4 V at 400 V/s, and reapplied at a frequency of
10 Hz [62,67,68]. Using this waveform and other developed waveforms, FSCV has been
used to probe not only DA and serotonin (5-HT), but also other oxidizable neurochemicals,
such as 3,4-dihydroxyphenylacetic acid (DOPAC), purines, ascorbic acid (AA), adenosine,
norepinephrine (NEP), oxygen, pH changes, and hydrogen peroxide in vivo [38,60–66]. Im-
provements in selectivity and sensitivity have been achieved through further development
of FSCV waveforms and application rate optimization. Development has also expanded
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NT measurement from phasic to tonic quantification and worked to increase technique
safety and address biofouling effects on the chemical measurement [69–74].
The most commonly used materials for NT measurement with FSCV are carbon
fibers due to their biocompatibility, electrochemical, and conductive properties [75–78].
CFMEs have been the cornerstone of in vivo FSCV and a bevy of data exist for the detec-
tion of electroactive NTs like DA, serotonin (5-HT), DOPAC, and others. Ralph Adam’s
lab was the first to electrochemically measure DA in vivo using a carbon electrode con-
sisting of graphite mixed with mineral oil [79]. Later, CFMEs were developed and
used for dopaminergic and electrophysiological measurements in vivo, first published
by Gonon [80], and then by Armstrong-James and Millar in 1979 [81]. Using the CFME,
in 1981, Millar developed the technique of FSCV that was later popularized by Wight-
man [63,81–83]. A typical CFME consists of a carbon fiber that is aspirated into either a
glass or silica capillary, or encased in some other insulating medium, such as parylene-
C [74,84–86]. Electrodes also can be coated with polymers and other carbon-based mate-
rials to enhance the sensitivity and selectivity for various NTs [74,87–89]. Additionally,
CFME surfaces can be functionalized with ease to tune the electrode to increase selectivity
and decrease biofouling. Such coatings include: Poly(3,4-ethylenedioxythiophene) (PE-
DOT):Nafion [74], PEDOT:phosphorylcholrine [90], PEDOT: poly(ethyleneimine) (PEI) [88],
CFME:gold nanoparticle [91], carbon nanospikes [89,92], Nafion carbon nanotubes [93,94],
polycrystalline boron doped diamond [95,96], and carbon nanotube yarn [97,98]. Each coat-
ing has been tailored to not only increase sensitivity to NTs such as DA, but also to decrease
the effects of biofouling and increase in vivo sensor lifetime.
Table 1. Summary of neurotransmitter detection techniques.
Techniques Advantages Shortcomings Reported LOD
PET High spatial resolution Complex manipulationVery high cost Dopamine: 200 nM [99]
SPECT High spatial resolution Complex manipulationVery high cost
SERS Very high sensitivity andselectivity
Can be inapplicable in vivo





FSCV High sensitivity Low selectivityElectrode short lifetime Dopamine: 50 nM
Amperometry Low implementation cost Low sensitivity andselectivity Dopamine: 10 nM [100]
HPLC High sensitivity andselectivity
High cost and complex
manipulation
Fluorescence High sensitivity andselectivity May not be usable in vivo Dopamine: 10 pM
Chemilumin-escence High sensitivity, and ease tocouple with other methods
Indirect measurement through
the loss of a signal due to a
binding event
6 nM
Optical Fiber Sensing High selectivity Low sensitivity Glutamate: 0.22 µM




Table based on S. Niyonambaza et al. (reproduced from [28] under a Creative Com-
mons Attribution 4.0 International License).
Despite their advantages, CFMEs have drawbacks which have motivated the search
for alternative materials for in vivo FSCV. CFMEs are brittle and easily broken during
insertion into the brain. Likewise, their long-term stability is compromised by dissolu-
tion of the carbon fiber electrode material that can result in significant degradation and
loss of sensitivity over time. CFMEs are often fabricated through proprietary mecha-
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nisms, using low-throughput assembly methods, and are designed for industrial processes
rather than electrochemical purposes [101]. Recently, boron doped diamond (BDD) deposi-
tion and growth processes were developed that enable the wafer patterning and growth
of custom-deposited carbon electrodes [96,102–105]. Through these growth processes,
BDD was grown on tungsten wires and carbon fiber surfaces. More recently, custom
BDD microelectrodes (BDDMEs) encapsulated with polycrystalline diamond were devel-
oped [96,101,104,106,107]. BDD is an attractive material because it has a low background
current, a wide potential window, and good biocompatibility [108–110]. Using BDD,
Rusinek et al. showed that BDDMEs were suitable for neurochemical measurement using
an all-diamond-electrode rather than the deposition of BDD onto another medium [103].
As carbon fibers are proprietarily fabricated, limiting the modification of the material for
an optimized structure–function relationship, BDD electrodes are attractive due to the
tunability of the carbon sp2 to sp3 ratio [111–114]. Increasing the sp2 character of the BDD
increases the density of electronic states, and provides catalytic sites for redox reactions
through adsorption sites. By using the BDD growth process, electrodes can be further tai-
lored to enhance specific electrochemical properties. Such modifications include adjusting
the structure–function relationship of the material to enhance conductivity, decrease capac-
itance, and increase chemical functionalization for selectivity and sensitivity. Additionally,
recent advances in electrode array technologies for voltammetric measurements include
multi-barrel glass capillary arrays [115,116], patterned arrays on silicon wafers [117,118],
or parylene-C insulated multichannel carbon fiber electrode arrays [85,119]. While these
arrays are powerful, most rely on hand fabrication processes under a microscope and are
cumbersome, and slow. Open opportunities remain to improve the design and performance
of carbon-based neurochemical sensors, including the development and optimization of
diamond-based electrodes.
2. Motivation for Diamond Sensors for Neurochemical Detection
For FSCV, it is desirable for the electrode to display both high sensitivity (detecting
minute concentrations of the neurochemical of interest) in addition to high selectivity
(reliably differentiating the neurochemical of interest from interferents). Historically, the ad-
vantages of diamond electrodes have been counterbalanced by tradeoffs in sensitivity
relative to CFMEs. While optimal translation of the positive in vitro performance character-
istics of diamond electrodes to the chronic in vivo setting remains an unmet opportunity,
there are advantageous characteristics of diamond which motivate further development.
2.1. Batch Fabrication and Customization
While CFMEs often rely on manual assembly techniques that can be cumbersome
and low-throughput, BDD electrodes can be patterned in a variety of architectures and
batch-fabricated. To create BDD microelectrodes and multielectrode arrays (MEAs), several
different approaches have been explored, which are typically divided into bottom-up
approaches relying on chemical vapor deposition (CVD) growth of microstructures or
top-down approaches by etching or machining BDD to produce microstructures [120].
A common approach to fabricate BDD microelectrodes in a probe format is the overgrowth
of CVD BDD on the tip of sharpened and insulated metal (e.g., tungsten or platinum)
microwires [96,121–125], followed by insulating the wire with pre-pulled glass capillar-
ies [123,124], heated polypropylene pipette tips [125], or chemical vapor deposited parylene
C (Figure 1A [96]). However, this approach has drawbacks. Exposing the same electrode
geometry each time and up-scaling the device to high-density MEAs are the main chal-
lenges. To produce well-defined, high-density BDD MEAs, an alternative bottom-up
approach has been demonstrated [126,127], wherein the diamond seed layer was pre-
patterned prior to CVD growth, resulting in a patterned BDD film directly from the CVD
process (Figure 1B [126] and Figure 1C [127]). In contrast, top-down methods grow a
continuous BDD film on a seeded planar substrate (e.g., silicon or silicon dioxide wafers)
followed by micromachining the BDD film to create microelectrode patterns via plasma
Micromachines 2021, 12, 128 5 of 28
dry etching [128,129] or laser ablation (Figure 1D [130]). Figure 2 shows schematically
these two typical fabrication methods for making all diamond microelectrode probes
and MEAs. To further improve the mechanical flexibility, pre-patterned BDD MEAs
can be transferred from a solid substrate onto a soft polymer substrate, such as poly-
norbornene [131], polyimide [132] and parylene C [133,134] to form BDD-on-polymer
MEAs with reduced mechanical rigidity (Figure 1E [131] and Figure 1F [133]). Recently,
BDD paste electrodes suitable for electroanalytical applications have been reported by
Kondo et al., offering a cheaper alternative to fabrication of flexible BDD MEAs [135,136]
(Figure 1G [136]). These glucose sensing electrodes were constructed by screen printing of
a glucose-oxidase-immobilized cobalt phthalocyanine/boron-doped diamond powders on
a polyimide substrate. While these devices enable multi-channel sensing with improved
spatial resolution, their large dimensions increase the risk of tissue damage and scar tissue
formation. Our group has recently reported the fabrication of all-diamond, microelectrode
fibers with a minimized footprint (Figure 1H [103]).
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microelectrode array made of nanocrystalline BDD (reproduced from [126] with permission *). (C) Nanocrystalline BDD
deposited on a pre-patterned high aspect ratio silicon pillar electrode (reproduced from [127] with permission). (D) All
diamond microelectrode probe with polycrystalline BDD electrodes and traces insulated by undoped diamond thin films.
(reproduced from [130] with permission *). (E) A flexible diamond-on-polymer electrode array fabricated by transferring
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window is often known as the water potential windo . BDD exhibits an extremely wide
potential window in aqueous solution and quasi-reversible kinetics with low background
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ated the electrochemical potential window of BDD fiber electrodes in pH 7.4 ph sphat
buffered saline (PBS) and 1.0 M H2SO4 using cyclic voltammetry (CV), as illustrated in
Figure 3. We used a thre -electrode cell with the diamond fiber as a working electrode
(WE), a platinum wire as a counter el ctrode (CE), and an Ag/AgCl electrode refe ence
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limit). As shown in Figure 3A, BDD fiber had a very wide potential window of ~5.0 V
in pH 7.4 PBS and ~4.0 V in 1.0 M H2SO4 and low background currents over these po-
te tial ranges. The potential window of a ~3 mm diameter BDD macroelectrode is much
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(Figur 3B). These properties are potentially desirable for applying BDD a an electr de
material in electrochemical sensing. The wid potential window f BDD electrodes theo-
retically could enable the detection of a wide variety of chemicals with extended anodic
potentials. Moreover, the very small background current of BDD electrodes can facilitate a
low detection limit of analytes, provided that the decrease in noise enables an increase in
signal-to-noise ratio (SNR).
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2.3. Selectivity
Selectivity for FSCV measu ment of neurotransmitters is achieved by assessing peaks
in Faradaic curr t that result from electroactive species. How ver, the co plex brain envi-
ronment cont ins variety of electr active speci s that comm ly produce overlapping
Faradaic currents that complicate the discrimination of n urotransmitters of interest from
interfere t olecules. The relative contributions of different neurotransmitters to Faradaic
currents recorded during FSCV depends not only on the reduction and oxidation potentials
for each molecule, but also on the adsorption properties and reaction kinetics. Increased
selectivity and specificity for specific neurotransmitters based on their adsorption and ki-
netic properties can be achieved by optimizing the waveform applied to an FSCV electrode.
For FSCV at CFMEs, characterization of how changing waveform properties affects the rep-
resentation of interferents has led to optimized waveforms for the measurement of specific
neurotransmitters including DA [140], adenosine [141], and serotonin [37] (5-HT). For ex-
ample, studies show that, by increasing the anodic potential limit of CFMEs from 1.0 to
1.4 V during a CV scan, increased sensitivity to DA was achieved [140]. The improvement
in sensitivity is mainly attributed to an increase in the adsorption properties of the CFMEs.
Unfortunately, etching occurs at potentials greater than 1.1 V for CFMEs, which can be ad-
vantageous for cleaning the electrodes to alleviate fouling [140,142], but also risks creating
drift in the background. This overoxidation of CFMEs by scanning over an extended poten-
tial window could cause a continuous loss of electrode mass, possibly due to evolution of
carbon dioxide [142,143]. In addition, the higher potential limit alters the electron transfer
kinetics at the CFMEs, causing a decrease in temporal response and decreased selectivity
for DA over interferents such as DOPAC, NE, and 4-hydroxy-3methoxyphenylethylamine
(3-MT) [62,140]. With the extended anodic potential, the peak oxidation potential for DA
became sharper and the sensitivity was enhanced by 9 ± 2 fold (in vivo) and 4.9 ± 2 fold
(in vitro). The extremely wide potential window and stability of BDD electrodes may
allow the anodic potential to be pushed to a higher limit to achieve better sensitivity of
electroanalysis while maintaining selectivity. Additionally, stable scanning to extended
anodic potentials enabled by the wide potential window may allow for measurement
of additional molecules with oxidation potentials beyond traditional FSCV waveforms.
Further, the extended scan range could potentially increase selectivity by enabling the
measurement of additional oxidation peaks at extended potentials, such as the secondary
oxidation peak for epinephrine that occurs at around 1.6 V due to the presence of a sec-
ondary amine that enables the differentiation of epinephrine and norepinephrine [38].
Thus far, the characterization of interferents at diamond electrodes has been very limited
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(Table 2), but will be an important factor in optimizing the selectivity of diamond electrodes.
The tradeoffs with wide potential window, selectivity, stability, and temporal resolution
described in this section should be carefully considered in the design and characterization
of BDD electrodes.
2.4. Sensitivity
The use of electrochemical sensors in the complex brain environment requires high
sensitivity and selectivity against other electroactive species that can interfere with the
analyte of interest. For example, interferents, such as DOPAC, AA, and uric acid (UA),
greatly hinder the electrochemical determination of DA in the brain, because these chemi-
cals exhibit much higher concentrations than those of DA and oxidize at similar potentials
to that of DA. Surface fouling due to accumulation of oxidized products on the electrode
surface further limits electrode selectivity and sensitivity in the long-term. While challenges
exist, the inherent robustness, electrochemical stability, wide potential window, and good
electrocatalytic activity of highly boron-doped polycrystalline or nanocrystalline diamond
electrodes make these materials suitable candidates to detect DA [96,105,133,144,145],
epinephrine (EP) [146], and NEP [147,148]. These electroactive NTs belong to the family
of catecholamines (e.g., DA), which are readily oxidized to an ortho-quinone that can be
electrochemically detected using pristine BDD electrodes without any surface modification
or functionalization. For example, Tyszczuk-Roko et al. tested BDD electrode for DA deter-
mination in biological samples and pharmaceutical preparation using CV and differential
pulse voltammetry (DPV), and obtained a limit of detection (LOD) of ca. 187 nM with
good linearity in a wide concentration range of 10 to 200 µM [144]. Most recently, our team
pushed the DA LOD of untreated BDD fiber electrodes to ca. 30 nM by increasing the scan
rate of FSCV to 900 V/s (see more details in the following section). Besides catecholamine
NTs, 5-HT, an indolamine NT, contains the phenolic group, which undergoes an oxidation
process leading to the formation of ketones. Electroanalytic sensing of 5-HT has also been
carried out on unmodified BDD electrodes by several groups, with achievable LOD down
to 10 nM [149–151]. A summary of the neurochemical sensing performance of the untreated
BDD electrodes is reported in Table 2.
Table 2. Neurotransmitter sensing performance of untreated BDD.
Electrode Linear Range/µM LOD/µM Sensitivity/µA µM−1 NTs/Interferents Detection Method Ref.
As deposited BDD 0.01–200 0.187 — DA/Paracetamol CV and DPV [144]
As deposited BDD
(fiber electrode) 0.05–10 0.03 — DA




As deposited BDD 0.01–100 0.01 0.017 5-HT CV [149]
As deposited BDD — 0.01 — 5-HT FSCV (in vivo) [152]
As deposited BDD 0.7–60 0.21 — EP SWV [146]
Nonetheless, studies thus far suggest that untreated diamond has lower sensitivity to
NTs of interest in comparison to CFMEs, perhaps in part due to lower adsorption. In some
studies, demonstrations of the sensing performance of diamond-based electrodes are based
on non-physiological, artificially high concentrations of DA. For example, in a comparison
of CFMEs and ultrananocrystalline diamond microsensors (UNCD), a DA uptake inhibitor
(nomifensine) was required to register a detectable DA signal on the UNCD electrodes
following implantation into the rat striatum [153]. However, competitive detection limits
to CFMEs were achieved through a combination of electrochemical pretreatment, UV expo-
sure, and creating a similar form factor to the CFME. These modifications were suggested
to reduce sp2 content, increase oxygen termination, and reduce the size of the electrode to
be more comparable to CFMEs. While Kitazawa and colleagues observed reduced sensitiv-
ity of diamond electrodes in comparison to CFMEs, they noted that waveforms had not
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been optimized for diamond, and performance was comparable using constant amperome-
try [154]. Anecdotally, a recent observation from our team indicated that the CFME offered
a ~14× increase in sensitivity in comparison to a BDD electrode, although it is notable that
the BDD electrode was 27× smaller in surface area compared to the CFME and not quite as
conductive (as indicated by an anodic shift of the DA oxidation peak). True 1:1 comparisons
of the performance of CFMEs and diamond electrodes can be challenging, particularly
considering differences in electrochemical surface area, as well as that waveforms and
instrumentation typically used for diamond electrodes were originally tailored to CFMEs.
Differences in the geometry of the electrodes can also play a role: electron transfer kinetics
vary at the edges versus the tip of CFMEs. Likewise, assessments of background drift,
biofouling, NT polymerization, and SNR should be included in comparisons of electrodes.
2.5. Biocompatibility
Material biocompatibility is an important consideration for implantable neural elec-
trodes. Biofouling is a key determinant of sensitivity, and both protein and cellular adhesion
have the potential to interrupt the performance of implanted sensors. Glial scarring and
neuronal loss can contribute to noise and effectively isolate the sensor from target electrical
and neurochemical signals [155,156]. The glial encapsulation can extend up to several
hundred microns from the implant center [157], which is typically ~10–100× the elec-
trode size. Glial encapsulation can present a diffusion barrier at the electrode interface,
with the potential to significantly degrade the transformation of neurochemical signals
to the electrode over time [155,158]. Diamond is a bioinert material with an established
track record of success as a candidate implant material [159]. In addition to its attractive
material properties (fracture toughness, corrosion resistance, etc.), diamond is recognized
as non-immunogenic and non-thrombogenic [159], with demonstrated biocompatibility
in both in vitro and in vivo settings [133,160,161]. For sensing applications, conductive,
boron-doped diamond exhibits fibrotic encapsulation and inflammatory responses which
are less than or equivalent to medical-grade silicone following implantation intramuscu-
larly in guinea pigs [160]. Notably, there may be a relationship between the level of dopant
and the degree of cellular adhesion, where increased cellular adhesion to more positive sur-
face potentials resulting from increased dopant is a possible underlying mechanism [160].
In retinal implants, diamond is a promising candidate encapsulation material, lacking
observable inflammation in tissue collected at the two week time point during a six month
intraocular implantation period in rabbits [161]. Likewise, polycrystalline diamond is a
biocompatible substrate for neuronal culture, illustrating similar neuritic arborization and
outgrowth to control cell culture plastic [133].
2.6. Flexibility
While diamond has been recognized as a biocompatible material, its rigidity has the
potential to exacerbate trauma to surrounding brain tissue, both during device insertion
and through subsequent cyclical damage resulting from the natural pulsatile micromotion
of the brain relative to a skull-fixed implant [157]. In the long term, the presence of stiff
implants may contribute to inflammatory responses, resulting in neural degeneration
and glial scar formation surrounding the implant. Fabrication of an electrode implant
with small dimensions, which improves mechanical flexibility through reduced bending
stiffness, is one solution to minimize the inflammatory response and prolong the functional
lifetime of the device. In neural sensing applications, subcellular dimensions have been
shown to facilitate a reduced tissue response to implanted electrode arrays [156]. Carbon-
based electrodes with small feature sizes (7 micron diameter) have demonstrated minimal
observable gliotic scarring and improved integration into surrounding brain tissue in
comparison to traditional, silicon-based electrodes [162]. Diamond electrodes for neural
sensing applications can be fabricated with similarly small device dimensions [103].
Bending stiffness, which is defined by both the device dimensions and the Young’s
modulus of the material, has emerged as a critical determinant of biocompatibility [163].
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By Euler’s formula, buckling force (Fbuckling) is defined as the force applied on a beam which
causes the beam structure to fail, and determined by the beam’s width, height, length,







where E is the Young’s modulus of diamond (105 GPa). Although diamond is stiffer than
most materials, a diamond fiber can have a bending stiffness as low as some polymer [164]
and carbon fiber [85] probes when the cross-sectional dimensions of the fiber are small
relative to the fiber length.
According to the theoretical modeling and finite-element analysis conducted in [157],
the substrate material should be as soft as possible to effectively integrate with brain tis-
sue. However, many “soft” materials, such as polydimethylsiloxane (PDMS), parylene-C,
and other materials with Young’s modulus smaller than 10 GPa [165] have limitations, or in
practice, “impossibilities” for applications in neural implants. For example, the fabrication
of such soft probes usually requires unconventional and tedious processes, and the surgical
insertion of the device to the target tissue requires temporary or permanent sheaths to rein-
force the mechanical rigidity and avoid buckling. Additionally, when the probe shank is
too soft as discussed, micromotions of the brain can cause displacement on electrodes [157],
resulting in inaccurate measurements from the same neurons. As such, an ideal implantable
electrode probe should be flexible and small to alleviate inflammation response and tissue
damage but mechanically stiff enough to facilitate device implantation to the tissue of
interest while preserving the implant from being broken in the brain environment [156,166].
Because diamond can be fabricated in subcellular dimensions, the device can retain com-
petitive bending stiffness while retaining adequate rigidity for insertion.
3. Opportunities for Optimization
The performance of diamond electrodes remains a challenge in the in vivo setting,
where interferents and biofouling can undermine the advantages of the wide potential
window to selective detection of neurochemicals of interest. Much fundamental work
remains to be completed in order to properly characterize and optimize neurochemical
detection with BDD electrodes, where surface modifications, waveform optimization,
and instrumentation tailored specifically to BDD electrodes are key opportunities to meet
remaining challenges.
3.1. Instrumentation
When comparing the performance of the CFME and diamond electrodes, it should also
be considered that the instrumentation (e.g., universal electrochemistry instrument (UEI)
built by the University of North Carolina Electronics Design Core Laboratory), software
(e.g., high definition cyclic voltammetry software (HDCV), University of North Carolina,
Chapel Hill, NC, USA), and flow cells used, are typically specifically engineered for the
CFME [167]. All of these components have been designed considering the CFME electrode
surface area/geometry, magnitude of the capacitive background current, and overall
electrode conductivity. Future iterations of BDD electrodes will also include changes to
the instrument hardware and software to better accommodate their specific properties.
Specifically, attributes such as headstage gain and capacitance compensation, either by
electronics or analog background subtraction, will be optimized for various BDD electrode
active areas. To accommodate BDD arrays, the hardware will be expanded to include
large channel capabilities, such as 16, 32, and 64 channels, requiring a shift in paradigm
from using a PC (personal computer) to manage data collection to using an FPGA (field
programmable gate array) to perform data collection at high speeds along with SOC
(system on chip) integrated circuitry. In addition, since BDD active areas can be precisely
controlled, electrodes with small areas can be used for probing transient electrochemical
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events [168]. This requires reductions in stray capacitances involving the method of
connection with the electrode as well as modifications to the front-end electronics for
improvement in bandwidth. Increases in instrumentation bandwidth can also facilitate the
use of electrochemical impedance spectroscopy (EIS) for monitoring electrode health for
extended operating times and the optimization of fast arbitrary waveforms for convolution-
based background subtraction [169]. Presently, the UEI instrumentation is capable of
performing simultaneous FSCV and electrophysiological measurements on four CFM
electrodes. The circuitry to accomplish this with BDD arrays, which are also capable of
single unit recordings, will need to be expanded.
3.2. Waveform
As noted previously, pure BDD has been shown to have an expanded water window
compared to platinum or carbon fiber, demonstrating that specific reactions such as water
electrolysis occur at different electrode polarization voltages. Similarly, the oxidation
peak for DA has been shown to shift, depending on the study, from the typical 0.6 V
for carbon fiber to ~1.0 V for more pure diamond. The potential limits and scan rates
of the waveform used can influence the surface concentration of a NT, as well as the
sensitivity and selectivity of the measurement [63]. For example, a negative potential
applied between scans is used to concentrate catecholamines to the electrode surface.
Several strategies have been employed to tailor waveforms to optimize the detection
of specific analytes of interest, including deviations from the standard triangular shape
(e.g., ‘sawhorse’), as well as within-scan changes in scan rate and amplitude of the sweep
sections composing the overall waveform. The waveform also can be designed to promote
release of adsorbed products on the surface of the electrode, alleviating the effects of
biofouling and polymerized neurochemicals. In essence, the change in material requires,
at a minimum, a re-optimization of the FSCV waveform to enhance sensitivity to a specific
neurochemical of interest, as well as understand selectivity versus potential interferents.
3.3. Sp2/Sp3 Content
Through the fabrication process for BDD, both sp2-hybridized and sp3-hybridized
carbon may be formed. Sp2-hybridized carbon is non-diamond carbon, such as graphite,
whereas a diamond crystal lattice is formed from sp3-hybridized carbon. Opportunities
to refine the sensitivity and selectivity of diamond electrodes include tuning sp2 car-
bon/impurity contents, surface morphology, and surface chemistry of BDD. Increased sp2
character decreases the stability of the material but also provides sites for neurotransmitter
adsorption. Long-term benchtop studies of BDD performance over time need to be con-
ducted to understand the stability of the capacitive and redox currents; both the slow loss
of sp2 carbon and the inability to ‘refresh’ the surface of pure diamond electrodes in the
presence of biofouling may dramatically impact sensitivity and/or selectivity over time.
Generally, sp2-bonded carbon promotes outer-shell or inner-sphere electron-transfer mech-
anisms, reduces the potential window, increases background current, and increases unde-
sired adsorption of chemical species [170–172]. On the other hand, as-grown BDD surfaces
are usually hydrogen-terminated and display relatively fast electron-transfer kinetics and
are electrically conducting via an unusual surface transfer doping mechanism [173–175].
These surfaces can be further refined using post-synthesis treatments such as alumina
polishing, oxygen plasma, electrochemical oxidation, and chemical functionalization to fit
end-user needs [176–180]. BDD surfaces terminated with oxygen functional groups (C=O,
C–OH, COOH) exhibit low surface conductivity and sluggish kinetics, but can limit the
impact of anionic interferents due to a lack of adsorption [173,174,179].
3.4. Surface Characteristics
Improving sensitivity of BDD electrodes also may be possible by increasing the elec-
trochemically active surface area for a given lateral dimension by increasing the fractal
dimension of the diamond electrode surface. This would provide more surface area for
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adsorption and mass transport of NTs. However, increased surface area increases the
non-Faradaic background current. In some cases, the increased background currents can
be large enough to saturate the input amplifier, in which case analog background sub-
traction can be applied using a UEI instrument with HDCV software and subtracting
headstage [181]. Besides electrochemically treated BDD, porous BDD offers unique advan-
tages including the large active area, strong surface adsorption, and high electron transfer
properties [182], making it a good electrode material for highly sensitive and selective NT
detection. Porous BDD can be created using plasma consisting of equal portions of H2
and Ar [183], or nanodiamond seeded SiO2 nanofiber templates [182], or vertically aligned
carbon nanotubes scaffold [184,185]. Similarly, May et al. fabricated high-surface-area
BDD electrodes using “black silicon”, a synthetic nanostructured material that contains
high-aspect-ratio nano-spikes or needles, as a template during BDD synthesis [186]. It is
yet to be determined whether or not these approaches will lead to long term improvements
in the presence of biofouling and the reactive tissue response to the implant.
3.5. Methods for Improved Selectivity
While interferents pose a challenge to selective detection of a NT of interest, separation
of signature redox peaks can be enhanced through anodic pretreatment. As a proof-
of-principle, it has been found that extensive anodic polarization in alkaline solution
improved the selectivity of BDD electrodes towards DA in the presence of large excesses
of AA [186,187], possibly due to the formation of oxygen-containing functional groups.
The anodic treatment was carried out by holding the electrode potential at +2.4 V (vs
Ag/AgCl) for 60 mins or at +2.6 V (vs SCE) for 75 min in 0.1 M KOH. The anodically
treated diamond electrode effectively shifted the oxidation peak potential of AA to higher
potentials while having minimal impact on the DA oxidation peak, resulting in large
peak separation in CV scans (Figure 4). Recently, selective determination of NEP in
the presence of lidocaine (LID) was demonstrated by Pınar et al. [188] using the BDD
electrodes that were anodically pretreated in 0.5 M H2SO4 at +1.9 V (vs Ag/AgCl) for 180 s.
High selectivity for DA in the presence of AA also can be achieved by surface hydrogenation
of BDD electrodes via electrochemical cathodic treatment or plasma hydrogenation [189].
Hydrogen-termination increases AA oxidation kinetics and surface absorption, resulting in
the downshift of the AA oxidation peak current to low potential. Surface modifications
can cause surface morphology change of the BDD electrode, and the anodic treatment may
also have a deactivating effect.
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Figure 4. (A) Cyclic voltammograms for 1 mM AA at untreated (dashed lines) and anodically treated (solid lines) diamond
electrodes in 0.1 M HClO4 solution. Sweep rate, 100 mV s−1. (B) Cyclic voltammograms for a mixture of 0.1 mM DA
and 1 mM AA at untreated (dashed line) and anodically treated (solid line) diamond electrodes in 0.1 M HClO4 solution.
Sweep rate, 100 mV s−1. (Reproduced from [187] with permission).
Surface functionalization using nanocomposites and polymers is an alternative strat-
egy to improve the selectivity and sensitivity of BDD electrodes. Among different nano-
materials, nanoparticles (NPs) like carbon black (CB) and gold NPs exhibit excellent
conductivity for fast electron transfer and a large number of defect sites, providing enough
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electrochemically active surface area. Moreover, negatively charged nanomaterials, such as
AuNPs/polyelectrolyte-coated polystyrene (Au/PE/PS) colloids, are found to have high
electrocatalytic activity that promotes the oxidation of DA while inhibiting the electrochem-
ical reaction of AA, thus enabling selective determination of DA in the presence of AA with
good sensitivity [190]. Such NP-based materials can be applied on the BDD surface in the
forms of self-assembled monolayers (SAM) [191], self-assembled multilayer stacks [190],
electropolymerized nanocomposite [192], or coating of NP-polymer suspension [189].
On the other hand, attempts also have been made to functionalize the BDD surface with
polymers for selective detection of DA. For example, poly(N,Ndimethylaniline) (PDMA)
coated BDD electrodes show a large negative shift (ca. 0.25 V) of the AA oxidation potential
and an increase in peak current resulted from the favorable electrostatic attraction between
the cationic PDMS film and anionic AA [193]. Likewise, Shang et al. modified the BDD
electrode with an electropolymerized PTy/PPA film that has inherently high permselec-
tivity of DA against 3,4-dihydroxyphenylalanine (L-DOPA), AA, uric acid, and other DA
metabolites [194]. Table 3 summarizes the neurochemical sensing performance of BDD
electrodes modified using different strategies.
Table 3. Comparison of various modification strategies for BDD electrodes.
Electrode Linear Range/µM LOD/µM Sensitivity/µA µM−1 NTs/Interferents Detection Method Ref.
Anodically treated BDD 1–70 0.05 — DA/AA Chronoamperometry [187]
Anodically treated BDD 1–100 0.27 — EP/LID SWV [188]
Anodically treated BDD 0.05–20 0.05 — DA/AA Chronoamperometry [105]
Plasma treated
porous BDD 0.1–100 0.06 1.05–1.14 DA/B6
Differential pulse
voltammetry (DPV) [183]
Porous BDD via SiO2
nanofiber template 0.25–10.0 0.2 0.157 DA/AA, UA CV & DPV [182]
BDD-coated black Si 0.3/0.5 0.27 9 DA/UA CV [186]
Carbon black/Nafion
modified porous BDD 0.1–100 0.054 — DA/AA, UA CV & SWV [189]
AuNPs/PANI/BDD 0.15–500 0.03 0.131 DA/AA CV & SWV [192]
Au/PE/PS-modified
BDD 5–100 0.8 0.059 DA/AA CV [190]
SAM/Au/BDD 0.01–10 0.001 0.00026 DA/AA, CV [191]
PPA/PTy-modified BDD ≤80 0.05 0.02 DA/AA, UA,L-DOPA Chronoamperometry [194]
PDMA film-coated BDD 0.2–2.6 0.06 0.363 DA/AA CV & SWV [193]
ECP-UV treated BDD,
ultrananocrystalline — 0.027 — DA FSCV (in vivo) [153]
Alumina-polished BDD 0.5–1 0.5 — 5-HT CV [195]
A contaminating signal due to changes in pH is an important consideration for the
use of BDD electrodes to detect NTs in the intact brain. It has been previously reported
by Takmakov and others that CFMEs are sensitive to pH change through surface electro-
chemistry involving a hydroquinone moiety [66]. They observed multiple peaks in their
FSCV response as pH was changed, primarily stemming from hydroquinone to quinone
(and back) transitions. In an assessment of these impacts on BDD electrode performance,
a recent observation from our group showed a normalized sensitivity that was 3–7× lower
for diamond than that obtained with a CFME previously. Thus, there may also be hydro-
quinone moieties on the BDD surface which are responding to the pH change, but perhaps
at a significantly less amount than that of a CFME. This result bodes well for the BDD
electrodes as local pH changes in an in vivo measurement would seemingly not affect
the capacitive background current as much as a CFME. Nonetheless, pH changes remain
a significant challenge in the in vivo environment (more so than other interferents such
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as AA, which change on a slower time course), and potential optimization strategies to
improve selectivity (Table 3) also should seek to mitigate these effects.
3.6. Stability
For carbon-based sensors, thermal stability decreases, the molecular adsorption (foul-
ing) increases, and the mechanical hardness decreases with increasing non-diamond sp2
content [96,196]. Kalish et al. found that a diamond film with over 80% sp3 content is
stable under a wide temperature range of 300–1270 K while a 40% sp3 film starts graphi-
tizing at 700 K [197]. The surface termination is an additional factor that affects the
electrochemical stability of a BDD electrode. As-deposited BDD usually has a non-polar,
hydrogen-terminated surface due to film growth in a hydrogen-rich environment, thus re-
ducing the adsorption of polar molecules [198]. However, this is controversial since
the hydrogen-termination is very unstable in air. Nevertheless, high-quality BDD with
hydrogen-termination and sp3-bonded carbon holds promise for suppressing the fouling ef-
fect and promoting the long-term stability of electrochemical analysis. Several studies show
that the BDD electrodes exhibited excellent chemical stability even after months of exposure
to biological and chemical environments [96,133,199–202]. For example, Rao et al. studied
the stability of the BDD film electrode for nicotinamide adenine dinucleotide (NADH) in
aqueous solution. The electrode response was reproducible for up to three months without
any specific pretreatment [200]. Park et al. also found that the unmodified BDD electrode
provided a highly stable response for exogenous NE in tissue for up to 7 h with response
attenuation of <8%, much better than that of a bare CF electrode (>30%) [201]. While these
studies are encouraging, further work is needed to explore translation of these benefits
from the benchtop to the in vivo environment; it is important to verify that improved
sensitivity does not come at the expense of altered selectivity.
3.7. Diamond Processing and Boron Doping
The performance of diamond electrodes can be further fine-tuned through the op-
timization of processing parameters. Diamond films may be grown using microwave
plasma enhanced or hot-filament chemical vapor deposition (CVD), where gas phase
carbon is deposited onto a substrate under certain pressures and temperatures. Boron dop-
ing of diamond materials may be accomplished by the introduction of diborane (B2H6),
trimethylborane (B(CH3)3), or organic borates in the gas phase during the growth pro-
cess, which alters the resulting film morphology, structure, and electrical properties [203].
Increasing the ratio of boron to carbon in the feedgas results in higher boron doping
concentrations, and subsequently higher electrical conductivity of the film [172,204,205].
The transition of BDD from semiconducting to metal-like behavior occurs at a known
boron concentration of 4–5 × 1020 atoms B cm−3 [206,207]. For electroanalytical sensing
applications, higher boron doping concentrations typically lead to higher sensitivity and
lower limits of detection [112,172]. This is due to increased charge carrier availability and
faster charge transfer kinetics at the electrode surface for the oxidation of organic species
compared to lowly doped BDD [112].
However, increasing the boron doping concentration can also decrease the potential
window of BDD electrodes [172], which limits the applicability of highly doped BDD as an
electrochemical sensor for certain analytes [112]. Furthermore, heavily doped BDD (>1021 B
atoms cm−3) can contain added sp2-bonded carbon impurities that decrease the stability
of the material [205,206,208]. These sp2-bonded carbon sites can also act as an adsorption
site for reactants, which can catalyze redox reactions for species such as DA [112,172,206].
This may explain why smaller grain sizes typically result in higher electrochemical activity
due to the prevalence of sp2-bonded carbon at the grain boundaries, as noted above [203].
With this in mind, an optimum boron doping concentration and sp3/sp2 ratio can be
selected for any particular electroanalytical sensing application, taking into consideration
the specific sensitivity, potential window, and material stability requirements. For example,
in small molecule sensing where high sensitivities are required, a boron concentration of
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~8000 ppm is commonly used [209–224]. This mid- to high-doping concentration yields a
material with high conductivity and moderate sp2 impurities compared to heavily doped
BDD [112]. Likewise, for neurochemical analysis, it is the increased sensitivity and fast
electron transfer kinetics of highly doped BDD that makes it suitable for detection of DA
and other NTs [105,145,187,225]. When a wider potential window is required, the usage of
BDD electrodes with lower boron concentrations may be used, albeit at the cost of decreased
sensitivity [112]. Based on the specific considerations for each application, the appropriate
electrode properties may be determined, and BDD films with these optimal characteristics
may be grown by adjusting the CVD conditions described above. The flexibility in the
BDD growth parameters allows for the synthesis of films with a wide range of electrical
and physical properties, and gives rise to the multitude of applications for BDD electrodes.
For instance, while increasing boron doping concentrations also decrease the film grain
size [172], larger grain sizes at higher boron doping levels may be achieved by increasing
the reaction pressure [204]. By adjusting film growth parameters, such as pressure, power,
temperature, feedgas composition, and growth time, the properties of the BDD film may
be tuned to fit the end use case.
3.8. Reference Electrodes
In vivo FSCV in animal models is normally performed as a two-electrode electro-
chemical measurement using a small CFME and a larger Ag/AgCl reference electrode.
Maintaining accurate applied voltages at the working electrode requires that the reference
electrode is not polarized, or pulled away from its open circuit potential, over the course
of a scan. This is achieved, in practice, by using a reference electrode with a much larger
surface area, compared to the working electrode, as well as by using Ag/AgCl, which has
low polarizability due to reversible reactions with chloride in solution. Although, Ag/AgCl
reference electrodes have become the de facto standard, they pose a problem for long-term
FSCV recordings due to degradation of the AgCl coating as well as adverse tissue reac-
tions, as shown in chronic in vivo applications. These tissue reactions are characterized by
extensive microglia encapsulation when the electrode is implanted within the CNS and
fibrous tissue encapsulation in the periphery. These problems have been well known for
decades. However, few alternative referencing strategies for FSCV have been explored.
While avoiding the potential toxicity of silver in vivo, stainless steel is problematic due
to ready polarization. While BDD electrodes have been proposed for long-term FSCV
applications, appropriate reference strategies are an often overlooked aspect of a complete
recording system. For long-term neurochemical recordings with diamond electrodes, it will
be critical to ensure biocompatibility of the implanted reference electrode and the use of a
reference electrode that has a stable potential over the course of a long-term implant.
3.9. Signal Processing
There are several challenges related to in vivo signal processing which have been
established for carbon-based electrodes, and these challenges likewise will need to be
considered for FSCV using diamond electrodes. The first step of FSCV signal processing
typically involves the subtraction of the background charging current, which has a much
larger amplitude than the Faradaic currents of interest. The background charging current
is affected by the scan rate as well as the electrode characteristics [63,68,226]. Changes
in the environment, temperature fluctuations, or changes to the recording surface itself
can influence this reference measurement. In an in vivo setting, there are added factors
that make the background subtraction even more unpredictable, disallowing a constant
reference for subtraction from the voltammogram. A convolution-based method has been
proposed as a potential solution for removing the background charging current [227].
In this method, the applied waveform and carbon fiber type are first optimized to simplify
the background currents to components that can be predicted by convolution. A small
voltage pulse applied immediately before each FSCV sweep is used to probe the electrode
impedance and estimate its impulse response function through discrete differentiation.
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Convolution with the FSCV waveform allows for prediction and digital subtraction of
the non-Faradaic background signal. On the other hand, it may be possible to extract
useful information from the background current; information contained in the background
charging current has been used to predict electrode sensitivity to sources of interference or
the analyte of interest [63]. Another approach uses the oxidation potential of quinone-like
moieties in the background signal as a predictor for the oxidation potential of DA [228].
Diamond is a material which generally exhibits lower capacitance and background currents
than CFMEs, and further work is needed to test and optimize approaches to extract and
assess the background signal with diamond electrodes.
Discrimination of the target NT of interest from interferents is an added challenge in
the in vivo setting. Principal component regression is a technique which has been used
to improve analysis of FSCV data collected. It performs the task of identifying the redox
peaks of the NT from all the voltammograms (~1000 s) collected using a combination of
principal component analysis (PCA) and multivariate regression. PCA applied to data
collected across the voltammograms is used for training a machine learning algorithm.
By comparing the principal components of the training set and the new data, the peaks
of the analyte of interest are identified. However, this method fails when discriminating
signals of similar variance. Another method known as the projection of latent structure
(PLS), or partial least square regression (PLSR), performs a similar task to PCR. Here,
PCA is performed twice: once for the predictor variables (voltammograms) and once
for the response variable (corresponding concentration values). The subsequent analy-
sis maximizes the covariance between the predictor and response variables. PLS is also
more robust towards multicollinearity which happens when the predictor variables are
highly correlated (i.e., individual current measurements in the voltammograms). In a
comparison of the methods of processing, PLSR yielded higher accuracy and improved
selectivity in the estimation of neurochemicals in both in vitro and in vivo data analy-
sis [228]. Another drawback of these approaches is the need to obtain a separate training
set for model generation, which can result in prediction errors if the training set is not
carefully constructed from consistent data measured within the same animal with the same
electrode. Multivariate curve resolution-alternating least squares (MCR-ALS) has been
discussed [229] as an alternate approach to deal with this issue, which uses raw data itself
to define component spectral and concentration profiles needing only the definition of
number of components. Other considerations are the processing time for data analysis and
errors due to bias. More recently, a novel image analysis technique was applied to color
plots to successfully discriminate simultaneous DA and adenosine signals [230]. There are
open opportunities to apply newer signal processing techniques to optimize NT detection
with diamond electrodes, particularly in the in vivo setting.
Notably, it has previously been established using CFMEs that motion, RF noise,
and electrical stimulation can generate an artificial signal in-vivo during FSCV that can
closely resemble a phasic change in DA or adenosine [231]. The extent to which these arti-
facts resemble neurochemical changes may functionally change depending on the electrode
material selected. Similarly, it is unclear for BDD electrodes if loss of sp2, DA polymeriza-
tion to the surface, and/or biofouling will impact selectivity (the ability to distinguish the
signal of interest from interfering signal such as pH change or oxygen change) in addition
to sensitivity. These reasons underscore the need to optimize signal processing algorithms
to establish selectivity in chronic use situations for new BDD FSCV materials.
4. Boron-Doped Diamond Microelectrodes (BDDMEs): A New Approach
Building on the state-of-the-art, our team is currently developing an all-diamond,
BDD fiber electrode for neurochemical sensing (Figure 1H [103]). The devices can be
batch-fabricated in customizable dimensions and geometries, as previously described [103].
We recently further simplified the fabrication process of the BDD fiber, taking advantage
of the conformal nature of the CVD method. In this approach, a continuous BDD film is
chemical vapor deposited on a seeded silicon wafer and patterned with a Ti/Cu mask to
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form the BDD fiber and contact. After dicing the wafer into small dies of devices, the silicon
substrate under the fiber shank is chemically etched to form a suspended structure while
the silicon under the contact region remained intact. In this case, silicon etching was
conducted by dipping the tip region in an HNA solution (acetic acid:nitric acid:hydrofluoric
acid = 55:35:20). Then microwave plasma assisted chemical vapor deposition (MPACVD)
was performed to grow microcrystalline PCD conformally over the BDD structure, followed
by laser cutting or mechanical cleavage to expose the recording site at the fiber tip. Finally,
the silicon substrate under the contact region is completely removed to release the fiber
and expose the contact pad. This simplified method requires only one lithographic mask,
and therefore, improves the fabrication precision by eliminating the misalignment between
masks. The pre-patterned Ti and Cu mask could be also utilized as a shadow mask to
create BDD fiber patterns directly from CVD growth, since diamond growth on Cu is much
slower than that on the seeded substrate.
Figure 5 shows data from our group which displays the chemical and electrical
sensing capabilities of BDD microelectrodes (BDDMEs). Recently, we also successfully
demonstrated the ability to use unmodified BDD fiber electrodes for ex vivo DA detection
at a fast speed (900 V/s) and with high sensitivity (30 nM), linearity, and specificity. Using a
three-electrode headstage, we performed FSCV to measure the sensitivity of DA using
a diamond fiber WE, platinum CE, and a Ag/AgCl RE. We found that an increase in
scan rate effectively improved the sensitivity towards DA, resulting in a 2× increase in
oxidation peak current at 900 V/s (Figure 5A). Using 900 V/s, 10 Hz, and a slightly modified
potential waveform (−0.7 to +1.2 V vs. Ag/AgCl), we calibrated the sensing performance
of the BDD fiber electrode for low DA concentrations (Figure 5B), and observed good
linearity from 50 nM–10 µM (R2: 0.998). We detected a clear oxidation peak of DA at
50 nM and obtained a limit of detection (LOD) of ca. 30 nM that is comparable to those of
existing DA sensing electrodes made of CF or glassy carbon [74,232]. In addition to sensing
neurochemical signals, BDDMEs are capable of detecting electrical signals generated by
neurons (Figure 5C). To establish proof-of-principle, a patch clamp electrophysiology rig
was used to both stimulate and record trains of action potentials from cultured rat cortical
neurons using methods previously described [133]. Simultaneously, a BDDME placed in
close proximity to the neuron was used to record the extracellular potential using a separate
board (Intan), where signals were timelocked via a 5 V TTL pulse from the patch digitizer.
Spikes in the extracellular potential were detected coincidently to intracellularly-recorded
action potentials (“ground-truth” data). While subject to further optimization of the signal-
to-noise ratio, these data demonstrate the ability of the BDDME to detect neuronal spikes
in the extracellular potential.
The high-throughput, customizable fabrication scheme, bending flexibility, small foot-
print, and multi-modal sensing capabilities are key advantages of BDDMEs as a novel
approach to diamond-based neurochemical sensors. However, development and charac-
terization of this technology is ongoing. New approaches to the FSCV waveform, instru-
mentation design, reference electrode, surface treatments, and signal processing are all
potential areas of future exploration for optimization of BDDMEs.
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5. Concluding Remarks
Loss or dysregulation of NTs underlies the debilitating consequences of neurode-
generative diseases, substance use disorders, and neuropsychiatric illnesses. Improved
technologies which can selectively and sensitively interrogate changes in neurochemicals
in the brain may open up new understanding and treatment options for these complex
disorders. For example, Parkinson’s disease is characterized by motor dysfunction that is
associated with loss of DA transmission caused by progressive degeneration of dopaminer-
gic innervation of the caudate and putamen. It has been estimated that at the time of motor
symptom emergence, 50–80% nigral DA neurons have been lost and even more pronounced
reductions in dopaminergic innervation in the putamen have already occurred [233,234].
Detection of subtle deficits in NT transmission is desirable for the preclinical testing and de-
velopment of new neuroprotective therapies. Likewise, simultaneous, real-time detection
of NTs across many sites could reveal new understanding of the neurochemical dynamics
in affective disorders involving multiple brain regions (e.g., depression). A recent study
which used FSCV to interrogate serotonin release in three disparate brain regions found
evidence of location-specific reuptake profiles [235]. Such knowledge may facilitate the
development of better-targeted and more effective drug treatments. Methods for sensing
neurochemicals in vivo would ideally be simultaneously sensitive, minimally-invasive,
and relatively inexpensive, while allowing detection with high spatiotemporal resolution
across multiple brain regions.
CFMEs, in combination ith FS , have created new opportunities to detect neuro-
chemicals in the intact brain with high spatiotemporal resolution. Nonetheless, limitations
remai with the mechanical integrity a d chronic sensing performance of CFMEs. Ad-
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ditionally, construction of CFMEs traditionally involves a multi-step, manual process
of threading a carbon fiber into a glass capillary, which is then heated, pulled, broken,
trimmed, and sealed with epoxy. Each step is prone to breakage and not well-controlled,
resulting in variability between electrodes. Diamond-based microelectrodes, as an alter-
native, offer a wide potential window, low background current, improved mechanical
stability, and more flexible fabrication schemes. While biofouling and loss of sensitivity
can be significant challenges in vivo, several opportunities exist to further develop and
optimize the performance of BDD sensors. Our team is pursuing the development of a
new, all-diamond fiber ultramicroelectrode as a next-generation neurochemical sensor.
These devices can be batch-fabricated and offer customizable architectures and site layouts,
potentially enabling “chemical mapping” of the neural circuitry underlying normal and
pathological brain function. Combined with strategies to optimize performance, diamond
electrodes are a promising candidate material for neurochemical sensing.
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144. Tyszczuk-Rotko, K.; Jaworska, I.; Jędruchniewicz, K. Application of unmodified boron-doped diamond electrode for determina-
tion of dopamine and paracetamol. Microchem. J. 2019, 146, 664–672. [CrossRef]
145. Soh, K.L.; Kang, W.P.; Davidson, J.L.; Wong, Y.M.; Cliffel, D.E.; Swain, G.M. Diamond-derived ultramicroelectrodes designed for
electrochemical analysis and bioanalyte sensing. Diam. Relat. Mater. 2008, 17, 900–905. [CrossRef]
146. Sochr, J.; Švorc, L’.; Rievaj, M.; Bustin, D. Electrochemical determination of adrenaline in human urine using a boron-doped
diamond film electrode. Diam. Relat. Mater. 2014, 43, 5–11. [CrossRef]
147. Park, J.; Galligan, J.J.; Fink, G.D.; Swain, G.M. In vitro continuous amperometry with a diamond microelectrode coupled with
video microscopy for simultaneously monitoring endogenous norepinephrine and its effect on the contractile response of a rat
mesenteric artery. Anal. Chem. 2006, 78, 6756–6764. [CrossRef] [PubMed]
148. Dong, H.; Wang, S.; Liu, A.; Galligan, J.J.; Swain, G.M. Drug effects on the electrochemical detection of norepinephrine with
carbon fiber and diamond microelectrodes. J. Electroanal. Chem. 2009, 632, 20–29. [CrossRef]
Micromachines 2021, 12, 128 25 of 28
149. Sarada, B.V.; Rao, T.N.; Tryk, D.A.; Fujishima, A. Electrochemical oxidation of histamine and serotonin at highly boron-doped
diamond electrodes. Anal. Chem. 2000, 72, 1632–1638. [CrossRef] [PubMed]
150. Patel, B.A. Continuous amperometric detection of co-released serotonin and melatonin from the mucosa in the ileum. Analyst
2008, 133, 516–524. [CrossRef]
151. Singh, Y.S.; Sawarynski, L.E.; Michael, H.M.; Ferrell, R.E.; Murphey-Corb, M.A.; Swain, G.M.; Patel, B.A.; Andrews, A.M.
Boron-doped diamond microelectrodes reveal reduced serotonin uptake rates in lymphocytes from adult rhesus monkeys
carrying the short allele of the 5-HTTLPR. ACS Chem. Neurosci. 2010, 1, 49–64. [CrossRef]
152. Halpern, J.M.; Xie, S.; Sutton, G.P.; Higashikubo, B.T.; Chestek, C.A.; Lu, H.; Chiel, H.J.; Martin, H.B. Diamond electrodes for
neurodynamic studies in Aplysia californica. Diam. Relat. Mater. 2006, 15, 183–187. [CrossRef]
153. Arumugam, P.U.; Zeng, H.; Siddiqui, S.; Covey, D.P.; Carlisle, J.A.; Garris, P.A. Characterization of ultrananocrystalline diamond
microsensors for in vivo dopamine detection. Appl. Phys. Lett. 2013, 102, 253107. [CrossRef]
154. Yoshimi, K.; Naya, Y.; Mitani, N.; Kato, T.; Inoue, M.; Natori, S.; Takahashi, T.; Weitemier, A.; Nishikawa, N.; McHugh, T.; et al.
Phasic reward responses in the monkey striatum as detected by voltammetry with diamond microelectrodes. Neurosci. Res. 2011,
71, 49–62. [CrossRef]
155. Salatino, J.W.; Ludwig, K.A.; Kozai, T.D.Y.; Purcell, E.K. Glial responses to implanted electrodes in the brain. Nat. Biomed. Eng.
2017, 1, 862–877. [CrossRef]
156. Thompson, C.H.; Riggins, T.E.; Patel, P.R.; Chestek, C.A.; Li, W.; Purcell, E. Toward guiding principles for the design of
biologically-integrated electrodes for the central nervous system. J. Neural Eng. 2020, 17, 021001. [CrossRef]
157. Subbaroyan, J.; Martin, D.C.; Kipke, D.R. A finite-element model of the mechanical effects of implantable microelectrodes in the
cerebral cortex. J. Neural Eng. 2005, 2, 103–113. [CrossRef]
158. Roitbak, T.; Syková, E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 1999, 28, 40–48. [CrossRef]
159. Nistor, P.A.; May, P.W. Diamond thin films: Giving biomedical applications a new shine. J. R. Soc. Interface 2017, 14. [CrossRef]
[PubMed]
160. Garrett, D.J.; Saunders, A.L.; McGowan, C.; Specks, J.; Ganesan, K.; Meffin, H.; Williams, R.A.; Nayagam, D.A.X. In vivo
biocompatibility of boron doped and nitrogen included conductive-diamond for use in medical implants. J. Biomed. Mater. Res.
Part B Appl. Biomater. 2016, 104, 19–26. [CrossRef] [PubMed]
161. Xiao, X.; Wang, J.; Liu, C.; Carlisle, J.A.; Mech, B.; Greenberg, R.; Guven, D.; Freda, R.; Humayun, M.S.; Weiland, J.; et al. In vitro
and in vivo evaluation of ultrananocrystalline diamond for coating of implantable retinal microchips. J. Biomed. Mater. Res. Part B
Appl. Biomater. 2006, 77, 273–281. [CrossRef] [PubMed]
162. Kozai, T.D.; Langhals, N.B.; Patel, P.R.; Deng, X.; Zhang, H.; Smith, K.L.; Lahann, J.; Kotov, N.A.; Kipke, D.R. Ultrasmall
implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces. Nat. Mater. 2012, 11, 1065–1073.
[CrossRef]
163. Stiller, A.M.; Black, B.J.; Kung, C.; Ashok, A.; Cogan, S.F.; Varner, V.D.; Pancrazio, J.J. A meta-analysis of intracortical device
stiffness and its correlation with histological outcomes. Micromachines 2018, 9, 443. [CrossRef]
164. Xu, H.; Hirschberg, A.W.; Scholten, K.; Berger, T.W.; Song, D.; Meng, E. Acute in vivo testing of a conformal polymer microelec-
trode array for multi-region hippocampal recordings. J. Neural Eng. 2018, 15. [CrossRef]
165. Weltman, A.; Yoo, J.; Meng, E. Flexible, penetrating brain probes enabled by advances in polymer microfabrication. Micromachines
2016, 7, 180. [CrossRef]
166. Wellman, S.M.; Eles, J.R.; Ludwig, K.A.; Seymour, J.P.; Michelson, N.J.; McFadden, W.E.; Vazquez, A.L.; Kozai, T.D.Y. A Materials
Roadmap to Functional Neural Interface Design. Adv. Funct. Mater. 2018, 28(12), 1701269. [CrossRef]
167. Bucher, E.S.; Brooks, K.; Verber, M.D.; Keithley, R.B.; Owesson-White, C.; Carroll, S.; Takmakov, P.; McKinney, C.J.; Wightman,
R.M. Flexible software platform for fast-scan cyclic voltammetry data acquisition and analysis. Anal. Chem. 2013, 85, 10344–10353.
[CrossRef] [PubMed]
168. Zhou, X.S.; Mao, B.W.; Amatore, C.; Compton, R.G.; Marignier, J.L.; Mostafavi, M.; Nierengarten, J.F.; Maisonhaute, E. Transient
electrochemistry: Beyond simply temporal resolution. Chem. Commun. 2016, 52, 251–263. [CrossRef] [PubMed]
169. Johnson, J.A.; Rodeberg, N.T.; Wightman, R.M. Measurement of Basal Neurotransmitter Levels Using Convolution-Based
Nonfaradaic Current Removal. Anal. Chem. 2018, 90, 7181–7189. [CrossRef] [PubMed]
170. Einaga, Y.; Foord, J.S.; Swain, G.M. Diamond electrodes: Diversity and maturity. MRS Bull. 2014, 39, 525–532. [CrossRef]
171. Duo, I.; Fujishima, A.; Comninellis, C. Electron transfer kinetics on composite diamond (sp3)-graphite (sp2) electrodes.
Electrochem. Commun. 2003, 5, 695–700. [CrossRef]
172. Garcia-Segura, S.; Vieira Dos Santos, E.; Martínez-Huitle, C.A. Role of sp3/sp2 ratio on the electrocatalytic properties of
boron-doped diamond electrodes: A mini review. Electrochem. Commun. 2015, 59, 52–55. [CrossRef]
173. Granger, M.C.; Witek, M.; Xu, J.; Wang, J.; Hupert, M.; Hanks, A.; Koppang, M.D.; Butler, J.E.; Lucazeau, G.; Mermoux, M.; et al.
Standard electrochemical behavior of high-quality, boron-doped polycrystalline diamond thin-film electrodes. Anal. Chem. 2000,
72, 3793–3804. [CrossRef]
174. Rossi, M.C.; Spaziani, F.; Salvatori, S.; Conte, G. Electronic properties of hydrogen and oxygen terminated surfaces of polycrys-
talline diamond films. Phys. Status Solidi 2003, 199, 71–76. [CrossRef]
175. Strobel, P.; Riedel, M.; Ristein, J.; Ley, L. Surface transfer doping of diamond. Nature 2004, 430, 439–441. [CrossRef]
Micromachines 2021, 12, 128 26 of 28
176. Notsu, H.; Fukazawa, T.; Tatsuma, T.; Tryk, D.A.; Fujishima, A. Hydroxyl groups on boron-doped diamond electrodes and their
modification with a silane coupling agent. Electrochem. Solid-State Lett. 2001, 4. [CrossRef]
177. Szunerits, S.; Boukherroub, R. Different strategies for functionalization of diamond surfaces. J. Solid State Electrochem. 2008, 12,
1205–1218. [CrossRef]
178. Dincer, C.; Ktaich, R.; Laubender, E.; Hees, J.J.; Kieninger, J.; Nebel, C.E.; Heinze, J.; Urban, G.A. Nanocrystalline boron-doped
diamond nanoelectrode arrays for ultrasensitive dopamine detection. Electrochim. Acta 2015, 185, 101–106. [CrossRef]
179. Hutton, L.A.; Iacobini, J.G.; Bitziou, E.; Channon, R.B.; Newton, M.E.; Macpherson, J.V. Examination of the factors affecting
the electrochemical performance of oxygen-terminated polycrystalline boron-doped diamond electrodes. Anal. Chem. 2013, 85,
7230–7240. [CrossRef] [PubMed]
180. Notsu, H.; Yagi, I.; Tatsuma, T.; Tryk, D.A.; Fujishima, A. Introduction of oxygen-containing functional groups onto diamond
electrode surfaces by oxygen plasma and anodic polarization. Electrochem. Solid-State Lett. 1999, 2, 522–524. [CrossRef]
181. Hermans, A.; Keithley, R.B.; Kita, J.M.; Sombers, L.A.; Wightman, R.M. Dopamine detection with fast-scan cyclic voltammetry
used with analog background subtraction. Anal. Chem. 2008, 80, 4040–4048. [CrossRef]
182. Baluchová, S.; Taylor, A.; Mortet, V.; Sedláková, S.; Klimša, L.; Kopeček, J.; Hák, O.; Schwarzová-Pecková, K. Porous boron doped
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